Accounts Submission

Accounts Submission

COAGULARE BIOMEDICA LIMITED - Company Information

Print Friendly Version

COAGULARE BIOMEDICA LIMITED

Company Registration Number:
08084652 (England and Wales)

Unaudited micro entity accounts for the year ended 31 March 2023

Period of accounts

Start date: 01 April 2022

End date: 31 March 2023

Page 1

COAGULARE BIOMEDICA LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2023

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

Page 2

COAGULARE BIOMEDICA LIMITED

Company Information

for the Period Ended 31 March 2023




Director: John McVey
Registered office: Chesterton
24 Woodchester Park
Knotty Green
Beaconsfield
Buckinghamshire
GBR
HP9 2TU
Company Registration Number: 08084652 (England and Wales)

Page 3

COAGULARE BIOMEDICA LIMITED

Directors' Report Period Ended 31 March 2023

The directors present their report with the financial statements of the company for the period ended 31 March 2023

Principal Activities

Consultancy services in biotechnology

Directors

The directors shown below have held office during the whole of the period from 01 April 2022 to 31 March 2023
John McVey

This report was approved by the board of directors on 29 September 2023
And Signed On Behalf Of The Board By:

Name: John McVey
Status: Director

Page 4

COAGULARE BIOMEDICA LIMITED

Profit and Loss Account

for the Period Ended 31 March 2023


2023
£
2022
£
Turnover 1,800 0
Income from coronavirus (COVID-19) business support grants 0 0
Other Income 0 0
Cost of Materials ( 0 ) ( 0 )
Staff Costs ( 0 ) ( 0 )
Depreciation and Writeoffs ( 0 ) ( 0 )
Other charges ( 1,298 ) ( 4,685 )
Tax on Profit ( 95 ) ( 0 )
Profit or (Loss) for Period 407 ( 4,685 )

Page 5

COAGULARE BIOMEDICA LIMITED

Balance sheet

As at 31 March 2023


2023
£
2022
£
Called up share capital not paid: 0 0
Fixed Assets: 0 0
Current assets: 3,286 7,776
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: ( 500 ) ( 1,700 )
Net current assets (liabilities): 2,786 6,076
Total assets less current liabilities: 2,786 6,076
Creditors: amounts falling due after more than one year: ( 0 ) ( 0 )
Provision for liabilities: ( 0 ) ( 0 )
Accruals and deferred income: ( 0 ) ( 0 )
Total net assets (liabilities): 2,786 6,076
Capital and reserves: 2,786 6,076

Page 6

COAGULARE BIOMEDICA LIMITED

Balance sheet continued

For the year ending 31 March 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 29 September 2023
And Signed On Behalf Of The Board By:

Name: John McVey
Status: Director

The notes form part of these financial statements

Page 7

COAGULARE BIOMEDICA LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 March 2023

  • 1. Employee Information

    Average number of employees: 0

Page 8

COAGULARE BIOMEDICA LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 March 2023

  • 2. Off balance sheet disclosure

    No

Page 9